International Clinical Expansion for Examen Lab Limited
Advanced Sperm DNA Testing for fertility clinics ready to look beyond standard semen analysis
Examen Global Supports IVF clinics, fertility hospitals, urologists, embryologists, and reproductive medicine leaders with advanced sperm DNA Fragmentation Testing powered by SpermComet® Technology.
Helping clinical terms indentify hidden male factor insights that count, motility, and morphology assessment may not fully reveal.
Examen Lab Limited, Belfast, UK
25 years of research heritage
SpermComet® technology
International clinic onboarding support
Clinical Integration Lead
Dr. Deepak Songra BDS
Global Development Manager, MEA, UAE, India,
and International Markets
Male Fertility Diagnostics- That looks beyond the surface to uncover hidden sperm DNA damage.
The diagnostic gap
The male fertility diagnostic gap clinics can no longer ignore.
Standard semen analysis remains useful for assessing count, motility, morphology, and baseline parameters. However, clinics regularly encounter patients with apparently acceptable semen parameters who still face unexplained infertility, recurrent pregnancy loss, poor embryo development, or repeated ART failure.
Advanced Sperm DNA Testing can help clinicians ask better questions, strengthen counselling, and make more informed decisions within a complete male fertility pathway.
Traditional semen analysis
Count
Motility
Morphology
Volume
Baseline parameters
Advanced Sperm DNA Testing
Single strand DNA damage
Double strand DNA damage
Incidence of DNA damage
Deeper male factor insight
Clinical decision support
Paradigm shift
From legacy semen analysis to modern DNA level male fertility insight.
The fertility field has advanced in stimulation protocols, embryology, cryopreservation, and laboratory quality. EXAMEN Global helps clinics modernise the male factor pathway by adding deeper DNA level insight that complements existing assessment.
Past
Count, motility, morphology
Useful baseline information, but limited DNA level visibility.
Present
Sperm DNA Fragmentation Testing
Deeper insight into sperm DNA integrity where clinically appropriate.
Future
Integrated male fertility diagnostics
A stronger, evidence based pathway for clinics and patients.
Science and evidence
Evidence based Sperm DNA Testing backed by Examen research.
Examen’s scientific foundation is built around SpermComet® technology and published research into sperm DNA damage, including single strand and double strand fragmentation. Clinicians are encouraged to review Examen’s evidence base directly.
DNA level insight
Supports deeper assessment beyond count, motility, and morphology.
Responsible interpretation
Designed to complement clinical judgement, not replace it.
Clinician led pathway
Testing decisions should be made by appropriately qualified professionals.
Advanced Sperm DNA Fragmentation Testing for Global Fertility Clinics. Trusted Results. Better Decisions. Better Outcomes.
Clinic value
Why leading fertility clinics should consider Examen.
Deeper male factor insight
Advanced Sperm DNA Testing can help identify hidden sperm DNA damage that may not be visible through standard semen analysis alone.
Stronger clinical conversations
Supports more informed counselling around unexplained infertility, recurrent loss, previous ART failure, lifestyle factors, and urology referral.
Clinic differentiation
Clinics may consider Sperm DNA Testing in selected cases under appropriate clinical guidance and in line with local professional standards.
Commercially practical
Creates a premium diagnostic pathway that can support clinical quality, patient trust, and service differentiation.
International logistics support
Supports practical onboarding models for the UAE, MEA, India, GCC, UK, and other international markets.
No major capital investment
Clinics can access specialist Belfast based testing through structured logistics pathways rather than building complex onsite capability.
Partnership and logistics
Two practical models for international clinic onboarding.
EXAMEN Global is designed to support clinics that need a clinically credible and operationally practical pathway to Belfast based specialist testing.
01.
Regional laboratory hub model
For markets with licensed laboratory partners and established cold chain or international specimen movement infrastructure.
02.
Direct clinic dry shipper model
For high volume IVF clinics or fertility groups. A liquid nitrogen dry shipper can hold up to 100 vials and may reduce unit shipping costs when volume is sufficient.
Sample collection
Cryopreservation
Batch shipping
Belfast testing
Clinical reporting
Commitment
All logistics, sample handling, import, export, consent, regulatory permissions, and patient data requirements must be reviewed and approved according to the relevant health authority, laboratory, and legal frameworks in each jurisdiction.
Commercial value
Premium testing. Practical economics. Stronger patient pathways.
For clinics, the value of advanced Sperm DNA Testing is not only the test fee. It is the ability to strengthen the male fertility pathway, improve patient counselling, support more targeted decision making, and create a differentiated clinical service.
Indicative regional test pricing
AED 3,250 to AED 4,500
Subject to clinic model, region, logistics, volume, and local regulation.
د.إ1 AED 🇦🇪 = ₹26Source: CurrencyRate.today, (21:15, 17 Jun, 2026) INR 🇮🇳
Clinical pathway
Where Sperm DNA Testing may fit within the fertility pathway.
Clinics may consider Sperm DNA Testing in selected cases under appropriate clinical guidance and in line with local professional standards.
Unexplained infertility
Recurrent pregnancy loss
Previous IVF or ICSI failure
Poor embryo development
Male factor infertility
Older paternal age
Varicocele assessment pathway
Lifestyle or oxidative stress risk factors
Before repeat ART cycles where clinically appropriate
After urology or andrology review where indicated
ABout Examen
Specialist male fertility diagnostics from Belfast, United Kingdom.
Examen Lab Limited is a Belfast based specialist laboratory focused on advanced male fertility diagnostics. Through SpermComet® technology and a strong research heritage, Examen supports clinicians seeking deeper insight into sperm DNA damage and its potential relevance within the fertility pathway.
Clinical positioning
Commercial viability
Logistics and sample movement
Patient pathway integration
Regional partnership opportunities
ROI modelling
Meet your onboarding lead
Dr. Deepak Songra BDS
Global Development Manager, Examen Lab Limited
MEA, UAE, India and International Markets
Dr. Deepak Songra BDS is the Global Development Manager for Examen Lab Limited,
supporting the international expansion of Examen’s advanced Sperm DNA Testing services
across the UAE, MEA, India and wider global markets.
With more than 30 years of frontline clinical healthcare experience, Dr. Songra brings a rare
combination of clinical understanding, patient pathway insight, commercial awareness and
international healthcare relationship building. His background as a UK qualified dental
surgeon gives him a deep appreciation of how clinicians make decisions, how patients
experience diagnostic uncertainty, and how healthcare providers can integrate advanced
testing in a way that is clinically meaningful, operationally practical and commercially viable.
At ExamenGlobal, Dr. Songra works with IVF clinics, fertility hospitals, urologists,
embryologists, laboratory groups, male wellness centres and healthcare partners to help
introduce advanced Sperm DNA Testing into clinical and commercial pathways. His role is to
support international clinics in understanding where Sperm DNA Fragmentation testing can
add value, how Examen’s SpermComet® technology can complement existing fertility
investigations, and how the service can be integrated without unnecessary disruption to
existing workflows.
Dr. Songra’s focus is not simply to promote a test, but to build sustainable clinical
partnerships. He helps clinics evaluate the practical, financial and strategic considerations
involved in offering Examen Sperm DNA Testing, including clinical positioning, patient
communication, sample logistics, regional partnership models, pricing strategy, referral
pathways and ROI modelling.
By combining clinical credibility with commercial development experience, Dr. Songra
supports clinics that want to strengthen their male fertility diagnostic pathway, differentiate
their services, improve patient counselling and offer access to a more advanced level of
sperm DNA assessment.
By combining clinical credibility with commercial development experience, Dr. Songra
supports clinics that want to strengthen their male fertility diagnostic pathway, differentiate
their services, improve patient counselling and offer access to a more advanced level of
sperm DNA assessment.
Mission
To transform global reproductive medicine by providing clinicians
and patients with the most accurate, actionable sperm DNA
fragmentation data—enabling faster diagnoses, personalized
treatment plans, and ultimately shortening every couple's
emotional and financial journey to parenthood.
Vision
To make DNA level male fertility assessment a recognised and accessible part of modern reproductive medicine pathways across international markets.
Values
Scientific integrity, clinical responsibility, evidence based communication, patient centred care, commercial transparency, international partnership, and regulatory compliance.
Professional guide
The Clinic Leader’s Guide to Integrating Advanced Sperm DNA Testing into the Male Fertility Pathway.
A practical guide for IVF clinics, fertility hospitals, urologists, and reproductive medicine teams considering Sperm DNA Fragmentation Testing as part of a more complete male fertility assessment pathway.
Responsible communication
Built for responsible medical communication.
This website is intended for healthcare professionals, clinic leaders, and institutional partners. It does not provide patient specific medical advice. All testing decisions must be made by appropriately qualified clinicians.
DDA aligned design
WCAG 2.2 AA oriented accessibility
Clinician led interpretation
Regional regulatory review required
Clear medical disclaimers
Evidence based copy controls
FAQ
Questions clinic leaders often ask
Examen Sperm DNA Testing assesses sperm DNA damage that standard semen
analysis does not directly measure.
Standard semen analysis evaluates count, motility, and morphology. These parameters are
useful, but they do not directly assess DNA integrity inside the sperm cell. Examen’s
SpermComet® technology provides additional diagnostic insight by assessing sperm DNA
damage at the individual sperm cell level.
Sperm DNA Fragmentation testing can help clinics investigate hidden male factor
issues that may be missed by standard semen analysis.
This may be particularly relevant in cases involving unexplained infertility, recurrent
pregnancy loss, poor embryo development, repeated ART failure, advanced paternal age,
varicocele, lifestyle risk factors, oxidative stress, or borderline semen parameters. The test
should be used as part of a broader clinical assessment, not as a standalone diagnosis.
SpermComet® technology is designed to measure DNA damage in individual sperm
cells, including single and double strand DNA breaks depending on the test selected.
The Examen Exact® test measures total sperm DNA fragmentation, including both single
and double strand breaks. Examen’s Extend® test is designed to provide further insight into
double stranded DNA fragmentation. This distinction may help clinicians better understand
the nature of sperm DNA damage in selected patients.
Examen SpermComet® should be positioned as an advanced, highly specialised
Sperm DNA Fragmentation test with strong scientific heritage, not as a guaranteed
predictor of treatment outcome.
The comet assay is widely recognised in scientific literature as a sensitive method for
assessing DNA damage, and Examen’s SpermComet® technology provides single cell level
analysis. However, all “gold standard” claims must be carefully substantiated, jurisdiction
reviewed, and not presented as a guarantee of pregnancy, live birth, or treatment success.
Independent clinical guidelines note that the evidence base for Sperm DNA Fragmentation
testing has grown, while still requiring careful clinical interpretation.
Clinicians may consider Sperm DNA Fragmentation testing when male factor
contribution is suspected despite normal or borderline semen parameters.
Relevant clinical scenarios may include:
Unexplained infertility.
Recurrent miscarriage or pregnancy loss.
Repeated IVF or ICSI failure.
Poor embryo development.
Advanced paternal age.
Varicocele assessment.
Lifestyle or oxidative stress concerns.
Before choosing between treatment strategies.
After abnormal semen analysis where further insight is required.
The decision should remain with the treating clinician.
No, Sperm DNA Fragmentation testing complements semen analysis rather than
replacing it.
Semen analysis remains an important first line male fertility test. Sperm DNA testing
provides additional information about DNA integrity that cannot be fully inferred from count,
motility, or morphology alone.
Examen can help clinics offer deeper male fertility assessment without needing to
build specialist Sperm DNA testing infrastructure in house.
Potential clinic benefits include:
Improved male fertility pathway.
More complete diagnostic workup.
Better informed patient counselling.
Enhanced differentiation from competing clinics.
Additional evidence based diagnostic service.
Minimal disruption to existing clinical workflows.
Access to specialist laboratory expertise.
No major capital equipment requirement when using Examen as a referral laboratory.
Avoid saying this will definitely improve pregnancy rates or guarantee patient retention.
The main clinic cost considerations are the test fee, sample handling, shipping model,
staff time, and patient pricing strategy.
Clinics should evaluate:
Cost per test from Examen.
Whether samples are batched or shipped individually.
Courier and cryoshipper costs.
Consumables and sample preparation requirements.
Internal staff time.
Patient retail price.
Expected monthly test volume.
Whether a central hub model or individual clinic shipper model is more viable.
The clinic typically collects and prepares samples according to agreed protocols, then samples are shipped to Examen’s specialist laboratory for analysis. Final logistics depend on the country, clinic setup, courier requirements, sample type, and regulatory approvals.
For UAE, India, MEA, and international markets, the logistics model may involve:
Clinic level collection.
Central hub collection.
Batch shipping.
Cryoshipper or validated shipping container.
Export documentation.
Patient consent.
Chain of custody.
Coordination with Examen’s laboratory team.
The website should not promise universal shipping availability until country specific requirements are confirmed.
A hub model may suit countries or regions where multiple clinics can consolidate samples. Individual clinic shipping may suit high volume clinics or hospital groups that want direct control. The best model depends on test volume, geography, customs requirements, courier reliability, and commercial strategy.
A responsible onboarding pathway should include:
Introductory meeting.
Clinical and commercial suitability review.
Sample pathway mapping.
Training for relevant staff.
Documentation and consent review.
Pilot sample process.
Reporting workflow agreement.
Launch plan for clinician and patient education.
Reports should help clinicians understand the level and type of sperm DNA damage identified, while avoiding over interpretation. The report should be discussed with the patient by an appropriately qualified fertility professional.
Suggested wording:
“Your semen analysis tells us about sperm count, movement, and shape. Sperm DNA testing looks at whether the DNA carried by the sperm may be damaged. This may help us understand whether sperm DNA quality could be contributing to your fertility history.”
Avoid:
Guaranteed IVF success.
Guaranteed live birth.
Cure for infertility.
Replacement for clinician diagnosis.
Definitive cause in every case.
Overstated “gold standard” language without evidence and regulatory review.
The partnership is designed for clinics that want to strengthen male fertility diagnostics without adding unnecessary operational complexity.
It is different from a standard semen analysis because it does not only look at how sperm appear or move. It looks more deeply at DNA integrity, which may help your clinician better understand your fertility picture.
Single strand breaks affect one strand of DNA. Double strand breaks affect both strands and may be more difficult for the sperm cell to overcome. Examen explains this distinction in its patient education material.
Semen analysis checks visible sperm parameters such as count, motility, and morphology. It does not directly measure DNA damage inside sperm cells. If you have unexplained infertility, previous IVF or ICSI failure, recurrent miscarriage, or poor embryo development, your clinician may consider Sperm DNA Fragmentation testing.
The result gives you more information. It may help guide further investigation, lifestyle advice, urology referral, treatment planning, or repeat testing. You should interpret the results alongside a full medical and fertility history.
Sperm DNA testing may help identify hidden male factor issues and support more personalised treatment planning. However, fertility treatment outcomes depend on many male, female, embryology, laboratory, medical, and age related factors.
Some men with normal count, motility, and morphology may still have increased sperm DNA damage. This is why the test can be useful in selected cases where the clinical picture remains unclear.
You may wish to discuss the test with your clinician if there has been:
Unexplained infertility.
Recurrent miscarriage.
Repeated IVF or ICSI failure.
Poor embryo development.
Advanced paternal age.
Varicocele.
Smoking, obesity, heat exposure, toxins, or high oxidative stress risk.
A long period of trying to conceive without a clear explanation.
In many international markets, the most appropriate route is through a licensed fertility clinic or clinician so that results can be interpreted correctly.
Some tests provide a general fragmentation score. Examen’s SpermComet® approach is designed to assess DNA damage at individual sperm cell level, with specific Examen tests able to assess total DNA damage and double strand DNA fragmentation.
Your fertility specialist can advise whether it is relevant before treatment, after unsuccessful treatment, or as part of a wider male fertility investigation.
Book A Briefing
Coordinate your Clinical Integration Briefing with Dr. Deepak Songra BDS.
Select an optimal slot for a 30 minute clinical, commercial, and logistics review.
Current operational window
08:00 AM to 18:00 PM UK GMT. Available 7 days a week.
Dubai, UAE: GMT plus 4 hours.
Mumbai and Delhi: GMT plus 4.5 hours.
Request a clinic ROI Simulator
